Evidence map›Paper›PMID 36439691›Full record

ArticleOxidative medicine and cellular longevity2022

BHF177 Suppresses Diabetic Neuropathic Pain by Blocking PKC/CaMKII/ERK1/2/CREB Signaling Pathway through Activating GABA

Boyu Liu, Fengxi Guan, Jiapeng Zhao, Yao Niu, Hongbo Jiang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Boyu LiuDepartment of Endocrine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, China.ORCID https://orcid.org/0000-0003-1561-3275
Fengxi GuanDepartment of Ultrasonography, Yanggu People's Hospital, Yanggu 252300, China.
Jiapeng ZhaoDepartment of Neurosurgery, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, China.
Yao NiuDepartment of Endocrine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, China.
Hongbo JiangDepartment of Nutrition, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, China.
Xinxiang Medical University · CNPeople's Hospital of Yangzhong · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gamma-aminobutyric acid type B (GABA

Indexed as

Diabetes MellitusDiabetic NeuropathiesNeuralgiaAnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium ChlorideEpidermal Growth Factorgamma-Aminobutyric AcidMAP Kinase Signaling SystemNorbornanesPyrimidinesRatsReceptors, GABA-BSignal TransductionCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium ChlorideEpidermal Growth Factorgamma-Aminobutyric AcidN-(bicyclo(2.2.1)hept-2-yl)-2-methyl-5-(4-(trifluoromethyl)phenyl)-4-pyrimidinamineNorbornanesPyrimidinesReceptors, GABA-B

Identifiers

PMID36439691
PMCPMC9691330
OpenAlexW4309617648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.